ArticleJMIR medical informatics2025
Predictive Modeling of Osteonecrosis of the Femoral Head Progression Using MobileNetV3_Large and Long Short-Term Memory Network: Novel Approach.
Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deep learning in the diagnosis, staging, and prognosis of osteonecrosis of the femoral head: a systematic review.BMC musculoskeletal disorders · 2026Pooled it
- Deep learning models for osteonecrosis of the femoral head on MRI: a systematic review and meta-analysis of diagnostic performance, staging accuracy, and external generalizability.Skeletal radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The assessment of osteonecrosis of the femoral head (ONFH) often presents challenges in accuracy and efficiency. Traditional methods rely on imaging studies and clinical judgment, prompting the need for advanced approaches. This study aims to use deep learning algorithms to enhance disease assessment and prediction in ONFH, optimizing treatment strategies. Objective: The primary objective of this research is to analyze pathological images of ONFH using advanced deep learning algorithms to evaluate treatment response, vascular reconstruction, and disease progression. By identifying the most effective algorithm, this study seeks to equip clinicians with precise tools for disease assessment and prediction. Methods: Magnetic resonance imaging (MRI) data from 30 patients diagnosed with ONFH were collected, totaling 1200 slices, which included 675 slices with lesions and 225 normal slices. The dataset was divided into training (630 slices), validation (135 slices), and test (135 slices) sets. A total of 10 deep learning algorithms were tested for training and optimization, and MobileNetV3_Large was identified as the optimal model for subsequent analyses. This model was applied for quantifying vascular reconstruction, evaluating treatment responses, and assessing lesion progression. In addition, a long short-term memory (LSTM) model was integrated for the dynamic prediction of time-series data. Results: The MobileNetV3_Large model demonstrated an accuracy of 96.5% (95% CI 95.1%-97.8%) and a recall of 94.8% (95% CI 93.2%-96.4%) in ONFH diagnosis, significantly outperforming DenseNet201 (87.3%; P<.05). Quantitative evaluation of treatment responses showed that vascularized bone grafting resulted in an average increase of 12.4 mm in vascular length (95% CI 11.2-13.6 mm; P<.01) and an increase of 2.7 in branch count (95% CI 2.3-3.1; P<.01) among the 30 patients. The model achieved an AUC of 0.92 (95% CI 0.90-0.94) for predicting lesion progression, outperforming traditional methods like ResNet50 (AUC=0.85; P<.01). Predictions were consistent with clinical observations in 92.5% of cases (24/26). Conclusions: The application of deep learning algorithms in examining treatment response, vascular reconstruction, and disease progression in ONFH presents notable advantages. This study offers clinicians a precise tool for disease assessment and highlights the significance of using advanced technological solutions in health care practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.